Great news, all right, about the GRZ award. It shows the ICSID to be doing its job, and gives us KRY shareholders good reason to remain hopeful.
I can probably speak for a lot of lurkers who, like me, lack the experience, skill, or persistence to dig out the facts of the ongoing saga of Crystallex and post them here. It is everyone's good fortune that we have some among us who can--and do. Certainly we all benefit, and my heartiest gratitude to the various, but by no means sundry gentlemen who keep us so well informed. Cheers, guys.
Lope